2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee
Lesin: trmino general para cualquier cambio anormal en el tejido
The standard approach often begins with a low dose of semaglutide, commonly 0.25 mg weekly for the first four weeks, which serves primarily as an initiation dose to allow physiological adaptation rather than providing significant therapeutic effect
If you notice any of the following, reach out to your care team: Signs of infection at the injection site (increasing redness, warmth, swelling, or pus)
Do not use in patients with a previous hypersensitivity to OZEMPIC [see Contraindications (4), Adverse Reactions (6.2)]
Anecdticamente, muchos pacientes han recuperado el peso perdido poco despus de dejar de tomarlos